New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AxoGen, Inc.
AXGN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

583M

Medical - Devices

Next Earning date - 07 Nov 2024

583M

Medical - Devices

Next Earning date - 07 Nov 2024

13.31USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-64%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated October 27, 2024
1W 1.22 % 1M -5.06 % 3M 49.38 % 1Y 252.12 %

Key Metrics

Shape
  • Market Cap

    583.38M


  • Shares Outstanding

    43.83M


  • Share in Float

    41.33M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    13.31


  • Average Volume

    457990


  • Beta

    1.127


  • Range

    3.45-15.23


  • Industry

    Medical - Devices


  • Website

    https://www.axogeninc.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.36x

P/S Ratio

6.08x

P/B Ratio

0.5

Debt/Equity

-9.5%

Net Margin

$-0.4

EPS

How AXGN compares to sector?

P/E Ratio

Relative Strength

Shape

AXGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$208M

Shape333%

2025-Revenue

$0.04

Shape20%

2025-EPS

$36M

Shape-2306%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Raymond James

initialise

Previous: Not converted

2024-07-01

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.01
vs -0.09

Q4.22

arrow
arrow

N/A

-0.03
vs -0.08

Q1.23

arrow
arrow

N/A

-0.10
vs -0.20

Q2.23

arrow
arrow

N/A

-0.03
vs -0.06

Q3.23

arrow
arrow

+200%

0.01
vs -0.01

Q4.23

arrow
arrow

N/A

-0.06
vs -0.03

Q1.24

arrow
arrow

N/A

-0.06
vs -0.10

Q2.24

arrow
arrow

+267%

0.05
vs -0.03

Q3.24

arrow
arrow

-40%

0.01
vs 0.01

Q4.24

arrow
arrow

+120%

0.01
vs -0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+18%

37M  vs 31.2M

Q4.22

arrow
arrow

+15%

36.2M  vs 31.5M

Q1.23

arrow
arrow

+18%

36.7M  vs 31M

Q2.23

arrow
arrow

+11%

38.2M  vs 34.5M

Q3.23

arrow
arrow

+12%

41.3M  vs 37M

Q4.23

arrow
arrow

+19%

42.9M  vs 36.2M

Q1.24

arrow
arrow

+13%

41.4M  vs 36.7M

Q2.24

arrow
arrow

+26%

47.9M  vs 38.2M

Q3.24

arrow
arrow

+14%

47.1M  vs 41.3M

Q4.24

arrow
arrow

+13%

48.3M  vs 42.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-4%

-0.04
vs -0.08

Q4.22

arrow
arrow

-5%

-0.05
vs -0.04

Q1.23

arrow
arrow

-7%

-0.07
vs -0.05

Q2.23

arrow
arrow

-7%

-0.07
vs -0.07

Q3.23

arrow
arrow

-4%

-0.04
vs -0.07

Q4.23

arrow
arrow

-4%

-0.04
vs -0.04

Q1.24

arrow
arrow

-7%

-0.07
vs -0.04

Q2.24

arrow
arrow

-2%

-0.02
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

127

127
vs 114

11%

Q4.22

arrow
arrow

137

137
vs 127

8%

Q1.23

arrow
arrow

133

133
vs 137

-3%

Q2.23

arrow
arrow

137

137
vs 133

3%

Q3.23

arrow
arrow

119

119
vs 137

-13%

Q4.23

arrow
arrow

126

126
vs 119

6%

Q1.24

arrow
arrow

123

123
vs 126

-2%

Q2.24

arrow
arrow

126

126
vs 123

2%

Earnings Growth

Latest News